BHVN – biohaven pharmaceutical holding company ltd. common shares (US:NASDAQ)
Stock Stats
News
Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress [Yahoo! Finance]
Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress
Biohaven (NYSE:BHVN) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
Biohaven (BHVN): Assessing Valuation After Recent Share Price Boost [Yahoo! Finance]
Biohaven (NYSE:BHVN) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.
Form 4 Biohaven Ltd. For: Nov 17 Filed by: Clark George C.
Form 4 Biohaven Ltd. For: Nov 13 Filed by: Bailey Gregory
Form 4 Biohaven Ltd. For: Nov 13 Filed by: CHILDS JOHN W
Form 4 Biohaven Ltd. For: Nov 13 Filed by: Coric Vlad
Form SCHEDULE 13G Biohaven Ltd. Filed by: JANUS HENDERSON GROUP PLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.